Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01154543
What this trial is testing

Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes

Who this might be right for
HIV PositiveHerpes Simplex, Genital
Holdsworth House Medical Practice 42
Testing effectiveness (Phase 2)Study completedNCT00743340
What this trial is testing

Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine

Who this might be right for
HIV-1 Infection
Gilead Sciences 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02494986
What this trial is testing

A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies

Who this might be right for
Human Immunodeficiency Virus Type 1
Janssen Sciences Ireland UC 48
Large-scale testing (Phase 3)Ended earlyNCT01145417
What this trial is testing

Pregabalin Trial In HIV Neuropathic Pain

Who this might be right for
HIV-1 InfectionNeuropathic Pain
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 217
Testing effectiveness (Phase 2)UnknownNCT03539224
What this trial is testing

Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept.

Who this might be right for
HIV-1-infection
Instituto de Investigación Hospital Universitario La Paz 41
Large-scale testing (Phase 3)Active Not RecruitingNCT02938520
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

Who this might be right for
HIV Infections
ViiV Healthcare 631
Large-scale testing (Phase 3)Study completedNCT02071082
What this trial is testing

Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults

Who this might be right for
HIVHBV
Gilead Sciences 79
Not applicableStudy completedNCT00000896
What this trial is testing

Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)UnknownNCT01793818
What this trial is testing

Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein

Who this might be right for
AIDS
BIOSANTECH 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07816250
What this trial is testing

A Phase 2b Study Evaluating VH4011499 Capsid Inhibitor Long-Acting Injectable Plus Cabotegravir in Treatment Naïve Adults (CINERGY)

Who this might be right for
HIV Infections
ViiV Healthcare 200
Early research (Phase 1)Study completedNCT00141024
What this trial is testing

Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 84
Testing effectiveness (Phase 2)Study completedNCT00903682
What this trial is testing

A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIVAcquired Immunodeficiency Syndrome
Janssen-Cilag International NV 157
Not applicableActive Not RecruitingNCT01466582
What this trial is testing

Comorbidity and Aging With HIV

Who this might be right for
HIV-1-infectionComorbidityAgeing
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,148
Testing effectiveness (Phase 2)Looking for participantsNCT05419024
What this trial is testing

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

Who this might be right for
HIV
National Cancer Institute (NCI) 50
Post-approval studies (Phase 4)Ended earlyNCT03532425
What this trial is testing

B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults

Who this might be right for
HIV-1-infection
University of Alberta 28
Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Large-scale testing (Phase 3)UnknownNCT00025727
What this trial is testing

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

Who this might be right for
HIV Infections
GlaxoSmithKline 330
Testing effectiveness (Phase 2)Active Not RecruitingNCT07711210
What this trial is testing

Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations

Who this might be right for
Infection, Human Immunodeficiency Virus
Jiangsu Aidea Pharmaceutical Group Co., Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT00513513
What this trial is testing

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 7
Early research (Phase 1)Study completedNCT00052182
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Next Page